Paula Ruth Clemens MD
Associate Professor, Neurology, University of Pittsburgh School of Medicine
Join to view full profile
3471 5th AveSte 810Pittsburgh, PA 15213
Phone+1 412-692-4920
Dr. Clemens is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1988 - 1990
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 1985 - 1988- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Internal Medicine, 1984 - 1985
MCP-Hahnemann College of MedicineClass of 1984
Certifications & Licensure
PA State Medical License 1995 - 2026
TX State Medical License 1993 - 1995
MN State Medical License 1988 - 1993
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification dbMotion, dbMotion Inc., 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification MyUPMC, UPMC, 2012-2017
Clinical Trials
Publications & Presentations
PubMed
- Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL-23/CD93 Pathways in Muscle.Utkarsh J Dang, Yuan Fang, Daniele Sabbatini, Elena Pegoraro, Luca Bello
American Journal of Medical Genetics. Part A. 2026-08-18 - Prednisone, not vamorolone, suppresses novel serum bone and cartilage biomarkers associated with growth failure in children with Duchenne muscular dystrophy.Rebecca A Tobin, Utkarsh J Dang, Laura Hagerty, Leanne M Ward, Raoul Rooman
Scientific Reports. 2026-08-03 - Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.Paula R Clemens, Anders Berglund, Marianela Schiava, Meredith K James, Michael P McDermott
Neurology. 2026-07-14
Journal Articles
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingPaula R Clemens, Vamshi K Rao, Craig M Zaidman, JAMA Neurology
Authored Content
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 2020
Press Mentions
Spinal Cord Stimulation Restores Neural Function, Targets Key Feature of Progressive Neurodegenerative DiseaseFebruary 5th, 2025- ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular DystrophySeptember 27th, 2021
- Long-Term Viltepso Prevents Motor Function Decline in DMD BoysJuly 13th, 2021
Grant Support
- Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)UNIVERSITY OF PITTSBURGH AT PITTSBURGH2018–2028
- Pilot Trial of Vamorolone for the Treatment of Becker Muscular DystrophyUNIVERSITY OF PITTSBURGH AT PITTSBURGH2020–2025
- Vamorolone trial in Becker muscular dystrophyREVERAGEN BIOPHARMA, INC.2021–2024
- Network Of Excellence In Neuroscience Clinical Trials (Univ Of Pittsburgh Crs)National Institute Of Neurological Disorders And Stroke2011
- Becker Muscular Dystrophy: A Natural History Study To Predict Efficacy Of EXON SKNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
